Jaime Xinos's most recent trade in Achieve Life Sciences Inc. was a trade of 69,000 Common Stock done . Disclosure was reported to the exchange on Sept. 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Achieve Life Sciences Inc | Jaime Xinos | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Sep 2025 | 69,000 | 95,286 (0%) | 0% | 0 | Common Stock | |
| Achieve Life Sciences Inc | Jaime Xinos | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Sep 2025 | 49,000 | 0 | - | - | Performance Restricted Stock Unit (PRSU) | |
| Achieve Life Sciences Inc | Jaime Xinos | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 2.77 per share. | 04 Sep 2025 | 20,854 | 74,432 (0%) | 0% | 2.8 | 57,766 | Common Stock |
| Achieve Life Sciences Inc | Jaime Xinos | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Sep 2025 | 20,000 | 80,000 | - | - | Performance Restricted Stock Unit (PRSU) | |
| Achieve Life Sciences Inc | Jaime Xinos | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 180,000 | 180,000 | - | - | Stock Option (right to buy) | |
| Achieve Life Sciences Inc | Jaime Xinos | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 100,000 | 100,000 | - | - | Performance Restricted Stock Unit (PRSU) | |
| Achieve Life Sciences Inc | Jaime Xinos | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2025 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Achieve Life Sciences Inc | Jaime Xinos | Chief Commercial Officer | 06 Dec 2024 | 30,000 | 30,000 | - | - | Stock Option (right to buy) |